BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
Reliance Securities Maintains 'Buy' On Torrent Pharmaceuticals
Reliance Securities believes the Unichem acquisition is a strategic fit for Torrent Pharmaceuticals. According to the brokerage, Torrent Pharmaceuticals is seen improving the profitability of Unichem's product portfolio through its strong field force and distribution network.